Mellbin L - Search Results

1

Editors' highlight picks from 2023 in EHJ Open.

Bäck M, Banach M, Braunschweig F, De Rosa S, Flachskampf FA, Kahan T, Ketelhuth DFJ, Lancellotti P, Larsson SC, Mellbin L, Nagy E, Savarese G, Szummer K, Wahl D; European Heart Journal Open Section Editors. Bäck M, et al. Among authors: mellbin l. Eur Heart J Open. 2024 Feb 22;4(1):oeae008. doi: 10.1093/ehjopen/oeae008. eCollection 2024 Jan. Eur Heart J Open. 2024. PMID: 38390349 Free PMC article. No abstract available.

2

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, Probstfield J, Ramachandran A, Riddle M, Rydén LE, Zinman B, Afzal R, Yusuf S, Gerstein H; TIDE Trial Investigators. Punthakee Z, et al. Diabetologia. 2012 Jan;55(1):36-45. doi: 10.1007/s00125-011-2357-4. Epub 2011 Oct 29. Diabetologia. 2012. PMID: 22038523 Clinical Trial.

3

A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease.

Evans LM, Mellbin L, Johansen P, Lawson J, Paine A, Sandberg A. Evans LM, et al. Among authors: mellbin l. Endocrinol Diabetes Metab. 2021 May 15;4(3):e00259. doi: 10.1002/edm2.259. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277983 Free PMC article.

4

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Mellbin LG, Malmberg K, Norhammar A, Wedel H, Rydén L; DIGAMI 2 Investigators. Mellbin LG, et al. Eur Heart J. 2008 Jan;29(2):166-76. doi: 10.1093/eurheartj/ehm518. Epub 2007 Dec 21. Eur Heart J. 2008. PMID: 18156614 Clinical Trial.

5

Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.

Anselmino M, Mellbin L, Wallander M, Rydén L. Anselmino M, et al. Among authors: mellbin l. Rev Cardiovasc Med. 2008 Winter;9(1):29-38. Rev Cardiovasc Med. 2008. PMID: 18418307 Review.

6

Cardiovascular prevention in patients with diabetes and prediabetes.

Anselmino M, Gohlke H, Mellbin L, Rydén L. Anselmino M, et al. Among authors: mellbin l. Herz. 2008 Apr;33(3):170-7. doi: 10.1007/s00059-008-3105-5. Herz. 2008. PMID: 18568310 Review.

7

Is glucose normalization an evidence-based treatment for patients with type 2 diabetes mellitus?

Rydén L, Malmberg K, Mellbin L. Rydén L, et al. Among authors: mellbin l. Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):8-9. doi: 10.1038/ncpendmet0997. Epub 2008 Oct 28. Nat Clin Pract Endocrinol Metab. 2009. PMID: 18957955 No abstract available.

8

Implications of abnormal glucose metabolism in patients with coronary artery disease.

Anselmino M, Wallander M, Norhammar A, Mellbin L, Rydén L. Anselmino M, et al. Among authors: mellbin l. Diab Vasc Dis Res. 2008 Nov;5(4):285-90. doi: 10.3132/dvdr.2008.041. Diab Vasc Dis Res. 2008. PMID: 18958838 Free article. Review.

9

Overview of the importance of glycaemic control for cardiovascular events in the in-and out-patient setting.

Anselmino M, Malmberg K, Mellbin L, Rydén L. Anselmino M, et al. Among authors: mellbin l. Rev Endocr Metab Disord. 2010 Mar;11(1):87-94. doi: 10.1007/s11154-010-9136-2. Rev Endocr Metab Disord. 2010. PMID: 20204530 Review.

10

Glucose monitoring by means of an intravenous microdialysis catheter technique.

Hage C, Mellbin L, Rydén L, Wernerman J. Hage C, et al. Among authors: mellbin l. Diabetes Technol Ther. 2010 Apr;12(4):291-5. doi: 10.1089/dia.2009.0150. Diabetes Technol Ther. 2010. PMID: 20210568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page